Profil
Nick DeLong is the founder of Evolved Capital, Inc. He previously worked as the Head of Business Development at Tris Pharma, Inc. and as the Vice President of Corporate Development at iBio, Inc. He holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from Rutgers University- Newark.
Ehemalige bekannte Positionen von Nick DeLong
| Unternehmen | Position | Ende |
|---|---|---|
| IBIO, INC. | Corporate Officer/Principal | 01.06.2024 |
Evolved Capital, Inc.
Evolved Capital, Inc. Packaged SoftwareTechnology Services Develops web-based tool | Gründer | - |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Corporate Officer/Principal | - |
Ausbildung von Nick DeLong
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iBio, Inc.
iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Health Technology |
Rutgers University- Newark
Rutgers University- Newark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evolved Capital, Inc.
Evolved Capital, Inc. Packaged SoftwareTechnology Services Develops web-based tool | Technology Services |
















